Biotech and pharmaceutical organizations have increasingly large volumes of data at their disposal, yet most struggle to extract value from it. While many companies are keen to use artificial intelligence (AI) and machine learning (ML), a majority don’t have the necessary foundations in place for using AI in R&D digital transformation initiatives to be successful.
In this webinar, the featured speakers will explore the root causes behind this problem and describe how commonly found deficiencies in data quality, infrastructure and governance can be addressed. Attendees will also gain insights from two case studies that illustrate the importance of establishing and maintaining good data management practices, regardless of the size or stage of their digital journey.
Join this webinar to get insights on the most common barriers to leveraging AI in R&D data digital transformation and how to overcome them.
Eliot Randle, PhD, MBA, SVP, Digital Transformation, ProPharma
Dr. Eliot Randle is the Senior Vice President of Digital Transformation at Digital Lab Consulting (DLC). Eliot has over 25 years of experience in the biopharmaceutical industry, across the entire value chain from R&D to manufacturing and clinical. He has a long track record of helping companies transform their business through better use of data and technology. Eliot holds a BSc in Biochemistry, a PhD in Molecular Biology from the University of Manchester in the UK, and an MBA from Warwick Business School in the UK.
Dana Vanderwall, Senior Director, Digital Transformation, ProPharma
Dana Vanderwall is an innovative leader in scientific solutions for drug discovery and digital transformation with over 25 years of experience in Pharmaceutical/Biopharma R&D. He has experience in biochemistry, structural biology, computational chemistry, cheminformatics, IT and data strategy and product management for enterprise informatics software. Dana’s experience in industry collaborations and data standards includes leadership roles in the Allotrope Foundation; a Fellow of the Society for Laboratory Automation and Screening; contributions to projects within the Pistoia Alliance; member of the IUPAC Committee on Publications and Cheminformatics Data Standards and Chair of the IUPAC Subcommittee on HELM. Dana holds a BS in Biochemistry from the University of Wisconsin in Madison and a PhD from the University of Maryland College Park and is a member of the Business Architecture Guild and DAMA International.
Who Should Attend?
This webinar will appeal to R&D professionals who want to get greater insights from their data in the biotechnology and pharmaceutical industries in the following roles:
- Chief Scientific Officers (CSOs)
- Research informatics
- VPs and Directors of Research and Development
- VP and Directors of Digital Transformation and Digital Enablement
- Data Science
What You Will Learn
Attendees will gain insights into:
- The most common barriers to digital transformation and how to overcome them
- The foundations that need to be in place before embarking on artificial intelligence/ machine learning (AI/ML) initiatives
- The investments that other companies have made to accelerate the digital transformation of their business
For the past 20 years, ProPharma has improved the health and wellness of patients by providing advice and expertise that empowers biotech, med device, and pharmaceutical organizations of all sizes to confidently advance scientific breakthroughs and introduce new therapies. As the world’s largest RCO (Research Consulting Organization), ProPharma partners with its clients through an advise-build-operate model across the complete product lifecycle. With deep domain expertise in regulatory sciences, clinical research solutions, quality & compliance, pharmacovigilance, medical information, and R&D technology, ProPharma offers an end-to-end suite of fully customizable consulting solutions that de-risk and accelerate our partners’ most high-profile drug and device programs.